Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2024 / Mar / Measles Rears Its Ugly Head
Microbiology & Immunology Microbiology and Immunology Regulation and standards Guidelines and Recommendations Insights

Measles Rears Its Ugly Head

As another wave of the contagious disease hits communities across the world, we ask: how are health services responding?

By Jessica Allerton 03/28/2024 Discussion 2 min read

Share

First appearing sometime between the 11th and 12th centuries – after separating from the rinderpest virus, measles has moved in waves and remains a global concern. Before the first measles vaccine was introduced in 1963, the World Health Organization (WHO) estimates that 2.6 million deaths were caused by the disease each year (1).

In the following six decades, great strides have been made – thanks to widespread vaccination programs and vaccine development. But in recent months, we’ve seen measles outbreaks across the world (2) – from Yemen to India, to Ethiopia. Now, Europe is seeing a drastic rise in infection rates – and the UK has reported over 300 cases since October 2023. Researchers believe this surge of measles is due to a low uptake of vaccines during the COVID-19 pandemic. A Nature Explainer notes that only around 85 percent of children in England have received the vaccine by five years old (3) – a major decline from the 95 percent vaccination rate required for “herd immunity.”

As the UK’s National Health Service (NHS) launches a vaccination campaign to curb the infection, a health alert springs up from the Gold Coast Public Health Unit as measles takes a trip down under (4). Can Australia hold its own against the measles onslaught using a similar vaccine approach to the UK – or will we see a further rise of infection?

Even more recently, measles is making headlines in the US, with an outbreak originating from an elementary school in Florida and causing a resurgence across the nation. In addition to the 10 cases that have now been reported in Florida, data from the Center for Disease Control and Prevention suggests that this is only the tip of the iceberg. Since the beginning of the year, 35 cases have been reported across 15 states. Notably, measles was declared eliminated from the US in the year 2000, so how is this resurgence possible?

Containing the outbreak should have been a matter of priority. But Florida’s Surgeon General Joseph Ladapo’s irresponsible response has been to issue recommendations that diverge from standard public health advice. Though established protocol suggests early vaccination (ideally within three days of exposure) or quarantine for 21 days, Ladapo did not recommend that children were vaccinated and left it to parents to decide whether they should go back to school or not. 

Ladapo’s 2021 appointment to the role was already controversial because of his opposition to vaccinations during the COVID-19 pandemic; perhaps this measles episode should surprise no one. Regardless, the situation is likely to get worse before it gets better – in the meantime, children in the state are being put in danger of a deadly disease.

As action is taken across the world, will we see a slow decline of cases – or is vaccine hesitancy gaining too much ground? We’ll continue to monitor the measles outbreak in the upcoming weeks and months, so stay tuned for updates. In the meantime, we welcome your thoughts on the measles outbreak where you are.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. World Health Organization (2023). Available at: https://bitly.ws/3cZnN 
  2. CDC GOV (2024). Available at: https://bitly.ws/3cZnX
  3. Nature (2024). Available at: https://bitly.ws/3cZof
  4. Gold Coast Bulletin (2024). Available at: https://bitly.ws/3cZoy

About the Author(s)

Jessica Allerton

Deputy Editor, The Pathologist

More Articles by Jessica Allerton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Context Matters in Cancer Biology
Microbiology and Immunology
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

What’s New in Infectious Disease? (December 2021)
Microbiology and Immunology
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Microbiology and Immunology
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

2021: A Laboratory Medicine Roundup
Microbiology and Immunology
2021: A Laboratory Medicine Roundup

January 18, 2022

3 min read

From transgender health care to the power of pathology podcasts, we take a look at our most popular articles of the last year

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.